Nongenetic influences on cystic fibrosis outcomes

Current Opinion in Pulmonary Medicine

Volumn 17, Issue 6, 2011, Pages 448-454

  Schechter, Michael S ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c Section of Pulmonology   (United States)

Author keywords

cystic fibrosis; outcomes; secondhand smoke exposure; socioeconomic status; variation

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

CYSTIC FIBROSIS; DEATH; DIET; DISEASE COURSE; DISEASE REGISTRY; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; EVIDENCE BASED MEDICINE; GENETIC ANALYSIS; GROUPS BY AGE; HEALTH CARE DELIVERY; HUMAN; MENTAL HEALTH; NONHUMAN; NUTRITIONAL DEFICIENCY; PATIENT COMPLIANCE; POLLUTION; RACE DIFFERENCE; REVIEW; SELF CARE; SEX DIFFERENCE; SMOKING; SOCIAL CLASS; SOCIAL SUPPORT; STRESS;

ADULT; CYSTIC FIBROSIS; DISEASE PROGRESSION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RISK FACTORS; SOCIOECONOMIC FACTORS; TOBACCO SMOKE POLLUTION;

EID: 80053378791     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32834ba899     Document Type: Review

References (68)

1. Cystic Fibrosis Foundation. Cystic Fibrosis Foundation Patient Registry. 2010; 2009 Annual Data Report. Bethesda, Maryland.
2. Wolfenden LL, Schechter MS. Genetic and nongenetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev 2009; 10:32-36.
3. Cutting GR. Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci 2010; 1214:57-69.
4. Schechter MS. Nongenetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Resp Crit Care Med 2003; 24:639-652. (Pubitemid 38036759)
5. Schechter MS, Gutierrez HH. Improving the quality of care for patients with cystic fibrosis. Curr Opin Pediatr 2010; 22:296-301.
6. Vanscoy LL, Blackman SM, Collaco JM, et al. Heritability of lung disease severity in cystic fibrosis. Am J Respir Crit Care Med 2007; 175:1036-1043. (Pubitemid 46741755)
7. Britton J. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ 1989; 298:483-487. (Pubitemid 19072074)
8. Schechter MS, Shelton BJ, Margolis PA, FitzSimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med 2001; 163:1331-1337. (Pubitemid 32506595)
9. OConnor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics 2003; 111:e333-e339.
10. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995; 48:1041-1049.
11. Stephenson A, Hux J, Tullis E, et al. Higher risk of hospitalization among females with cystic fibrosis. J Cyst Fibros 2011; 10:93-99.
12. OConnor GT, Quinton HB, Kahn R, et al. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol 2002; 33:99-105. (Pubitemid 34123684)
13. Guilbault C, Stotland P, Lachance C, et al. Influence of gender and interleukin-deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in mice. Immunology 2002; 107:297-305. (Pubitemid 35356949)
14. Stallings VA. Gender, death and cystic fibrosis: is energy expenditure a component? J Pediatr 2003; 142:4-6. (Pubitemid 36106378)
15. Willis E, Miller R, Wyn J. Gendered embodiment and survival for young people with cystic fibrosis. Soc Sci Med 2001; 53:1163-1174. (Pubitemid 32758759)
16. Walters S. Sex differences in weight perception and nutritional behaviour in adults with cystic fibrosis. J Hum Nutr Diet 2001; 14:83-91. (Pubitemid 32303329)
17. Simon SL, Duncan CL, Horky SC, et al. Body satisfaction, nutritional adherence, and quality of life in youth with cystic fibrosis. Pediatr Pulmonol 2011; doi: 10.1002/ppul.21477 [Epub ahead of print].
18. Truby H, Paxton AS. Body image and dieting behavior in cystic fibrosis. Pediatrics 2001; 107:E92.
19. Orenstein DM, Nixon PA. Exercise performance and breathing patterns in cystic fibrosis: male-female differences and influence of resting pulmonary function. Pediatr Pulmonol 1991; 10:101-105.
20. Braun L. Race, ethnicity, and health: can genetics explain disparities? Perspect Biol Med 2002; 45:159-174. (Pubitemid 34522205)
21. Watts KDSR, Sullivan C, McColley SA. Increased prevalence of risk factors for mrobidity and mortality in the US Hispanic CF population. Pediatr Pulmonol 2009; 44:594-601.
22. Quittner AL, Schechter MS, Rasouliyan L, et al. Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States. Chest 2005; 137:642-650.
23. Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med 1990; 323:782-788. (Pubitemid 20303875)
24. Goss CH, Rubenfeld GD, Ramsey BW, Aitken ML. Clinical trial participants compared with nonparticipants in cystic fibrosis. Am J Respir Crit Care Med 2006; 173:98-104. (Pubitemid 43069794)
25. Wheeler BW, Ben-Shlomo Y. Environmental equity, air quality, socioeconomic status, and respiratory health: a linkage analysis of routine data from the Health Survey for England. J Epidemiol Community Health 2005; 59:948-954. (Pubitemid 41527420)
26. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr 2001; 138:699-704. (Pubitemid 32417671)
27. Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA 2005; 293:581-588. (Pubitemid 40171240)
28. Stutman HR, Lieberman JM, Nussbaum E, Marks MI. Antibiotic prophylaxis in infants and young children with cystic fibrosis: a randomized controlled trial. J Pediatr 2002; 140:299-305. (Pubitemid 34289705)
29. Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol 1998; 26:81-88. (Pubitemid 28381468)
30. Kerem E, Corey M, Stein R, et al. Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients. Pediatr Infect Dis J 1990; 9:494-498. (Pubitemid 20218406)
31. Armstrong D, Grimwood K, Carlin JB, et al. Severe viral respiratory infections in infants with cystic fibrosis. Pediatr Pulmonol 1998; 26:371-379. (Pubitemid 29024978)
32. Slieker MG, van den Berg JM, Kouwenberg J, et al. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study. Pediatr Pulmonol 2010; 45:601-607.
33. LiPuma JJ. Burkholderia cepacia. Management issues and new insights. Clin Chest Med 1998; 19:473-486; vi.
34. Ledson MJ, Gallagher MJ, Jackson M, et al. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre. Thorax 2002; 57:142-145. (Pubitemid 34123888)
35. Hiatt PW, Grace SC, Kozinetz CA, et al. Effects of viral lower respiratory tract infection on lung function in infants with cystic fibrosis. Pediatrics 1999; 103:619-626. (Pubitemid 29274510)
36. Borowitz D, Robinson KA, Rosenfeld M, et al. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr 2009; 155:S73-S93.
37. Busse WW, Kiecolt-Glaser JK, Coe C, et al. NHLBI Workshop summary. Stress and asthma. Am J Respir Crit Care Med 1995; 151:249-252.
38. Patterson JM, Budd J, Goetz D, Warwick WJ. Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics 1993; 91:383-389. (Pubitemid 23042321)
39. Cruz I, Marciel KK, Quittner AL, Schechter MS. Anxiety and depression in cystic fibrosis. Semin Respir Crit Care Med 2009; 30:569-578.
40. Riekert KA, Bartlett SJ, Boyle MP, et al. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest 2007; 132:231-237. (Pubitemid 47068226)
41. Hudson CG. Socioeconomic status and mental illness: tests of the social causation and selection hypotheses. Am J Orthopsychiatry 2005; 75:3-18. (Pubitemid 40261725)
42. Borowitz D. The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis. Curr Opin Pulm Med 1996; 2:457-461. (Pubitemid 126440639)
43. Schoni MH, Casaulta-Aebischer C. Nutrition and lung function in cystic fibrosis patients: review. Clin Nutr 2000; 19:79-85. (Pubitemid 30316020)
44. James WP, Nelson M, Ralph A, Leather S. Socioeconomic determinants of health. The contribution of nutrition to inequalities in health. BMJ 1997; 314:1545-1549. (Pubitemid 27216077)
45. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35:246-259.
46. Kawchak DA, Zhao H, Scanlin TF, et al. Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis. J Pediatr 1996; 129:119-129. (Pubitemid 26277255)
47. Anthony H, Paxton S, Bines J, Phelan P. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis. J Psychosom Res 1999; 47:623-634. (Pubitemid 30029310)
48. Cohen-Cymberknoh M, Shoseyov D, Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am J Respir Crit Care Med 2011; 183:1463-1471.
49. Flume PA, OSullivan BP, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007; 176:957-969. (Pubitemid 350127838)
50. Flume PA, Robinson KA, OSullivan BP, et al. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009; 54:522-537.
51. Robinson KA, Saldanha IJ, McKoy NA. Management of infants with cystic fibrosis: a summary of the evidence for the Cystic Fibrosis Foundation Working Group on care of infants with cystic fibrosis. J Pediatr 2009; 155:S94-S105.
52. Mahadeva R, Webb K, Westerbeek RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998; 316:1771-1775. (Pubitemid 28269150)
53. Eakin MN, Bilderback A, Boyle MP, et al. Longitudinal association between medication adherence and lung health in people with cystic fibrosis. J Cyst Fibros 2011; 10:258-264.
54. Briesacher BA, Quittner AL, Saiman L, et al. Adherence with tobramycin inhaled solution and healthcare utilization. BMC Pulm Med 2011; 11:5.
55. Patterson JM, McCubbin HI, Warwick WJ. The impact of family functioning on health changes in children with cystic fibrosis. Soc Sci Med 1990; 31:159-164. (Pubitemid 20345722)
56. Gudas LJ, Koocher GP, Wypij D. Perceptions of medical compliance in children and adolescents with cystic fibrosis. J Dev Behav Pediatr 1991; 12:236-242.
57. DiMatteo MR. Enhancing patient adherence to medical recommendations. JAMA 1994; 271:79-82.
58. Eddy ME, Carter BD, Kronenberger WG, et al. Parent relationships and compliance in cystic fibrosis. J Pediatr Healthcare 1998; 12:196-202. (Pubitemid 128644605)
59. Schechter MS. Demographic and center-related characteristics associated with low weight in pediatric CF patients. Pediatr Pulmonol 2002; Suppl 22:156-157.
60. Konstan MW, Butler SM, Schidlow DV, et al. Patterns of medical practice in cystic fibrosis. Part II: Use of therapies. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol 1999; 28:248-254. (Pubitemid 29468458)
61. Konstan MW, Butler SM, Schidlow DV, et al. Patterns of medical practice in cystic fibrosis. Part I: Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Pediatr Pulmonol 1999; 28:242-247. (Pubitemid 29468457)
62. Johnson C, Butler SM, Konstan MW, et al. Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest 2003; 123:20-27. (Pubitemid 36126709)
63. Institute of Medicine Committee on Quality Healthcare in America. Crossing the quality Chasm: a new health system for the 21st century. Washington, DC: National Academy Press 2001.
64. McPhail GL, Weiland J, Acton JD, et al. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med 2010; 164:957-960.
65. Schechter MS, McColley SA, Silva S, et al. Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr 2009; 155: 634-639.
66. Schechter MS, McColley SA, Regelmann WE, et al. Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis. J Pediatr 2011 [Epub ahead of print].
67. Stephenson A, Hux J, Tullis E, et al. Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario, Canada. Pediatr Pulmonol 2011; 46:376-384.
68. Henley LD, Hill ID. Global and specific disease-related information needs of cystic fibrosis patients and their families. Pediatrics 1990; 85:1015-1021. (Pubitemid 20184722)